or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    APLM F Apollomics Inc. -9.11
    APTO F Aptose Biosciences, Inc. -22.13
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Acute Myeloid Leukemia Biopharmaceutical Cancer Clinical Medicine Medicine Oncology Phosphoinositide 3 Kinase Inhibitor Antineoplastic Drugs Bacterial Infections Bemcentinib Cancer Therapies Chemotherapy Drug Resistant Bacterial Infections Drugs Gemcitabine Hematologic Cancers Hematologic Malignancies Immunotherapy Leukemia Non Small Cell Lung Cancer

    Targeted Therapy Stocks Recent News

    Date Stock Title
    Nov 22 APTO S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
    Nov 22 APTO Aptose Biosciences to sell 40M shares at $0.20 in public offering
    Nov 22 APTO Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
    Nov 21 APLM Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
    Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medicine Clinical Medicine Cancer Biopharmaceutical Drugs Biomarkers Biotechnology Oncology Precision Medicine Solid Tumors Advanced Solid Tumors Antineoplastic Drugs Biology Blastoma Breast Cancer Cancer Immunotherapy Cell Biology Chemotherapy Clinical Development Colorectal Cancer
    Targeted Therapy

    Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

    Browse All Tags